Increased risk of hypereosinophilia following initiation of glucagon-like peptide 1 receptor agonist: A symmetry analysis using the Danish health registries

Martin Torp Rahbek*, Søren Andreas Just, Kasper Bruun Kristensen, Hussam Mahmoud Sheta, Jesper Hallas, Anton Pottegård, Lars Christian Lund

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

1 Downloads (Pure)
Original languageEnglish
JournalJournal of Internal Medicine
Volume296
Issue number6
Pages (from-to)527-530
ISSN0954-6820
DOIs
Publication statusPublished - Dec 2024

Keywords

  • adverse reactions
  • antidiabetics
  • glucagon-like peptide-1 receptor agonists
  • hypereosinophilia
  • pharmacoepidemiology

Cite this